13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q4 2016. See the latest, Q3 2026 →

Reported value

$1.03B

−9.3% on the quarter before

Positions

32

19 new, 28 sold out

Top 10

62.5%

of the value

Est. gain

+$12.3M

on stocks held all quarter

Est. return

+4.2%

on those stocks since Q3 2016

Filed

Feb 14, 2017

On SEC EDGAR ↗

Positions as of Dec 31, 2016, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.

Ishares Tr13%
Abbvie Inc7.5%
8 others6.9%
Bank Amer Corp5.5%
Halliburton Co5.5%
Select Sector SPDR Tr5.4%
Citigroup Inc5.4%
Pnc Finl Svcs Group Inc5.3%
Wells Fargo & Co New5.2%
Select Sector SPDR Tr5.0%
Lyondellbasell Industries N4.8%
Merck & Co Inc3.9%
Eog Res Inc3.8%
Freeport-McMoRan3.7%
Alcoa Corp3.3%
Jpmorgan Chase & Co2.8%
Nucor Corp2.1%
Ac Immune Sa2.0%
Pioneer Nat Res Co2.0%
Yahoo Inc1.8%
Bhp Billiton Ltd1.1%
Aspen Technology Inc1.1%
Everpure1.0%
Transocean Ltd1.0%
Williams Companies1.0%

Largest buys

Since Q3 2016, sized at quarter-end prices.

  1. Ishares Tr~$133.8MNew, 0.0% → 13.0% of the portfolio+991,900 shares
  2. Halliburton Co~$56.3MNew, 0.0% → 5.5% of the portfolio+1,041,300 shares
  3. Select Sector SPDR Tr~$55.7MNew, 0.0% → 5.4% of the portfolio+2,397,500 shares
  4. Citigroup Inc~$55.1MNew, 0.0% → 5.4% of the portfolio+927,100 shares
  5. Wells Fargo & Co New~$52.9MNew, 0.0% → 5.2% of the portfolio+960,400 shares
  6. Select Sector SPDR Tr~$51.5MNew, 0.0% → 5.0% of the portfolio+827,100 shares
  7. Lyondellbasell Industries N~$48.8MNew, 0.0% → 4.8% of the portfolio+568,500 shares
  8. Pnc Finl Svcs Group Inc~$46.4MAdded, 0.6% → 5.3% of the portfolio+396,500 shares
  9. Alcoa Corp~$33.7MNew, 0.0% → 3.3% of the portfolio+1,200,800 shares
  10. Jpmorgan Chase & Co~$28.3MNew, 0.0% → 2.8% of the portfolio+327,500 shares

Largest sells

Since Q3 2016, sized at quarter-end prices.

  1. Ishares Tr~$169.8MSold out, 15.0% → 0.0% of the portfolio−4,534,600 shares
  2. Alibaba~$49.8MSold out, 4.4% → 0.0% of the portfolio−470,600 shares
  3. Abbott Labs~$45.2MSold out, 4.0% → 0.0% of the portfolio−1,068,000 shares
  4. Broadcom Ltd~$34.8MSold out, 3.1% → 0.0% of the portfolio−201,900 shares
  5. Activision Blizzard Inc~$33.2MSold out, 2.9% → 0.0% of the portfolio−748,700 shares
  6. Barrick Gold Corp~$32.5MSold out, 2.9% → 0.0% of the portfolio−1,832,600 shares
  7. Amazon~$30.0MSold out, 2.7% → 0.0% of the portfolio−35,800 shares
  8. Agnico Eagle Mines Ltd~$28.8MSold out, 2.5% → 0.0% of the portfolio−530,800 shares
  9. Hdfc Bank Ltd~$27.2MSold out, 2.4% → 0.0% of the portfolio−378,600 shares
  10. Freeport-McMoRan~$26.3MCut, 4.7% → 3.7% of the portfolio−1,994,400 shares

Holdings

As of Dec 31, 2016; changes in shares since Sep 30, 2016.

Positions, sorted by share of the portfolio
HoldingValue
Ishares TrRUSSELL 2000 ETF · shares New13.0%$133.8M—
Abbvie IncCOM · shares −7.8% · price −0.7%7.5%$76.5M−$550,342
Bank Amer CorpCOM · shares +62% · price +41.2%5.5%$56.6M+$10.2M
Halliburton CoCOM · shares New5.5%$56.3M—
Select Sector SPDR TrSBI INT-FINL · shares New5.4%$55.7M—
Citigroup IncCOM NEW · shares New5.4%$55.1M—
Pnc Finl Svcs Group IncCOM · shares +571% · price +29.8%5.3%$54.5M+$1.9M
Wells Fargo & Co NewCOM · shares New5.2%$52.9M—
Select Sector SPDR TrSBI INT-INDS · shares New5.0%$51.5M—
Lyondellbasell Industries NSHS - A - · shares New4.8%$48.8M—
Merck & Co IncCOM · shares 0% · price −5.7%3.9%$40.3M−$2.4M
Eog Res IncCOM · shares +41% · price +4.5%3.8%$38.5M+$1.2M
Freeport-McMoRanCL B · shares −41% · price +21.5%3.7%$38.0M+$6.7M
Alcoa CorpCOM · shares New3.3%$33.7M—
Jpmorgan Chase & CoCOM · shares New2.8%$28.3M—
Nucor CorpCOM · shares +80% · price +20.4%2.1%$21.5M+$2.0M
Ac Immune SaSHS · shares +5.3% · price −21.2%2.0%$20.5M−$5.2M
Pioneer Nat Res CoCOM · shares +106% · price −3.0%2.0%$20.2M−$303,125
Yahoo IncCOM · shares New1.8%$18.7M—
Bhp Billiton LtdSPONSORED ADR · shares 0% · price +3.3%1.1%$11.6M+$368,000
Aspen Technology IncCOM · shares New1.1%$11.5M—
EverpureCL A · shares −53% · price −16.5%1.0%$10.5M−$2.1M
Transocean LtdREG SHS · shares New1.0%$10.3M—
Williams CompaniesCOM · shares +18% · price +1.3%0.99%$10.2M+$114,272
Dover CorpCOM · shares New0.99%$10.2M—
Total 32 positions100%$1.03B+$12.3M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2016 to Q4 2016: 13 stocks held throughout, up $12.3M (+4.2%).

  1. Bank Amer Corp+$10.2M+41%
  2. Freeport-McMoRan+$6.7M+21%
  3. Nucor Corp+$2.0M+20%
  4. Pnc Finl Svcs Group Inc+$1.9M+30%
  5. Eog Res Inc+$1.2M+5%
  6. Pioneer Nat Res Co−$303,125−3%
  7. Abbvie Inc−$550,342−1%
  8. Everpure−$2.1M−17%
  9. Merck & Co Inc−$2.4M−6%
  10. Ac Immune Sa−$5.2M−21%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free